PRP therapy at The Michigan Center for Regenerative Medicine uses a patient’s concentrated platelets, injected into selected joints, tendons, or related tissues, often with ultrasound guidance.

It may modestly reduce pain and improve function in knee osteoarthritis and certain tendinopathies, but it does not reliably restore cartilage, repair ruptures, or correct instability.

Suitability depends on diagnosis, severity, medications, comorbidities, and prior treatment.

Infection, bleeding disorders, and urgent surgical conditions require caution or deferral.

Learn more at Michigan Center for Regenerative Medicine about preparation, recovery, risks, and costs.

Main Takeaways

• PRP uses concentrated platelets from your own blood, injected into a joint or tendon, often with ultrasound guidance.
• Growth factors may support local tissue repair and inflammation control, but results vary by injury, preparation, and patient factors.
• PRP may help selected tendinopathies, mild-to-moderate osteoarthritis, and partial ligament or cartilage injuries after conservative treatment.
• Candidates need a confirmed diagnosis, appropriate imaging, realistic goals, and shared decision-making with a qualified clinician.
• PRP should be deferred for infection, uncertain diagnoses, urgent surgical conditions, complete ruptures, advanced joint destruction, or unsupported indications.

What Is PRP Therapy for Joint Injuries?

Platelet-rich plasma (PRP) therapy for joint injuries is a regenerative treatment that uses a concentrated preparation of a patient’s own blood platelets. A clinician draws venous blood, processes it through centrifugation, and injects the resulting platelet concentrate into a selected joint or adjacent tendon under sterile conditions. Depending on the injury, ultrasound or other imaging may guide placement to improve anatomical accuracy.

PRP is distinct from corticosteroid injections, hyaluronic acid, and laboratory-expanded cell products. It does not constitute stem cell therapy, and responsible counseling should correct stem cell myths that promise guaranteed cartilage replacement or universal pain relief. Treatment selection requires assessment of joint pain causes, including osteoarthritis, ligament injury, tendinopathy, meniscal pathology, inflammatory disease, or referred pain from the spine. Medical history, physical examination, imaging, medications, bleeding risk, and patient goals inform eligibility. Evidence remains condition-specific, with outcomes varying by preparation method, diagnosis, and disease severity. Its purpose is to support individualized care rather than replace established rehabilitation or surgical indications.

How Does PRP Support Healing?

PRP may support recovery by concentrating growth factors that influence cellular signaling at the injured joint tissues. These mediators can promote fibroblast activity, vascular responses, and extracellular-matrix remodeling involved in tissue repair. Clinical outcomes vary according to injury type, PRP composition, and the treated anatomical structure.

Growth Factors At Work

During recovering, concentrated platelets release signaling proteins that influence the local cellular environment at the injured joint. This platelet signaling includes growth factors such as platelet-derived growth factor, transforming growth factor-beta, and vascular endothelial growth factor. Their effects are primarily local and depend on tissue condition, injection technique, and the underlying injury. These mediators can influence vascular permeability, recruit responsive cells, and modify communication among synovial, connective-tissue, and immune cells. They may also help coordinate controlled inflammation, an vital phase of healing rather than a process that should be eliminated entirely. Evidence suggests PRP’s biological effects vary substantially according to platelet concentration, leukocyte content, preparation method, and patient factors. Accordingly, clinicians should present PRP as a supportive biologic intervention, not a guaranteed solution, while tailoring recommendations to each patient’s anatomy, diagnosis, and goals.

Tissue Repair Support

As tissue repair progresses, platelet-rich plasma (PRP) may support recovery by concentrating signaling molecules at the injury site, where they can influence fibroblasts, chondrocytes, synovial cells, and local immune cells. These effects may help coordinate extracellular-matrix production, angiogenesis, and modulation of inflammatory activity, rather than directly rebuilding cartilage or restoring a tendon.

1. Platelet-derived mediators may encourage fibroblast activity and collagen organization during tendon or ligament recovery.
2. In synovial tissues, PRP may alter inflammatory signaling and support a more favorable healing environment.
3. In cartilage-related injuries, potential benefits remain variable and depend on lesion characteristics and treatment design.

Clinical assessment determines patient eligibility, including diagnosis, comorbidities, medications, and functional goals. Protocol customization—such as platelet concentration, leukocyte content, injection number, imaging guidance, and rehabilitation timing—helps align treatment with tissue biology. Evidence remains condition-specific; PRP complements, not replaces, structured rehabilitation and appropriate medical care.

Which Joint Injuries May Benefit From PRP?

PRP may benefit selected tendon, ligament, cartilage, and mild-to-moderate degenerative joint injuries, including conditions affecting the knee, shoulder, hip, and ankle. Outcomes depend on the injured tissue, lesion severity, chronicity, mechanical alignment, and the presence of osteoarthritis or instability. Patient selection, injection accuracy, and standardized preparation protocols also influence the likelihood of clinical improvement.

Common Joint Injuries Treated

Common joint injuries that may benefit from platelet-rich plasma (PRP) therapy include osteoarthritis-related cartilage degeneration, meniscal tears, ligament sprains, and tendon injuries affecting the knee, shoulder, hip, ankle, elbow, and wrist. PRP may be considered for:

1. Knee osteoarthritis, patellar tendinopathy, meniscus sprains, or partial ligament injuries.
2. Shoulder rotator-cuff tendinopathy, labral irritation, or acromioclavicular joint degeneration.
3. Hip, ankle, and elbow tendinopathies, cartilage defects, or ligament inflammation.

Treatment is generally directed toward localized, nonoperative injuries rather than unstable fractures, complete tendon ruptures, or advanced joint destruction requiring reconstruction or replacement. Evidence is strongest for selected tendinopathies and mild-to-moderate osteoarthritis, while outcomes for cartilage, meniscal, and ligament lesions remain variable. A qualified clinician evaluates imaging, physical findings, functional limitations, and diagnosis before determining whether PRP is an appropriate supportive intervention for the affected joint.

Factors Affecting PRP Benefits

The potential benefit of platelet-rich plasma (PRP) depends on injury type, tissue quality, symptom duration, disease severity, and the integrity of the involved joint structures. Evidence is generally more supportive for tendinopathies, partial ligament injuries, and mild-to-moderate osteoarthritis than for complete ruptures, advanced cartilage loss, infection, or unstable fractures. Injury severity influences whether PRP can support recovery or whether surgical stabilization is necessary. Patient selection should consider age, activity demands, coexisting conditions, medications, and overall health status, including diabetes, inflammatory disease, and smoking. PRP preparation also matters: platelet concentration, leukocyte content, activation method, injection volume, and ultrasound-guided placement may affect biological activity and accuracy. Careful examination and imaging help identify viable tissue targets, set realistic expectations, and determine whether PRP is an appropriate adjunct to rehabilitation or surgery.

Could PRP Therapy Be Right for You?

Determining whether platelet-rich plasma (PRP) therapy is appropriate depends on the injury’s location, severity, duration, and response to conventional treatment. Patient selection criteria should be established through a structured clinical assessment, including physical examination, imaging, functional limitations, and treatment goals. Candidacy considerations also include the affected tissue, such as articular cartilage, tendon, ligament, or muscle, because recovery capacity and available evidence vary by anatomical site.

PRP candidacy depends on injury characteristics, affected tissue, clinical findings, treatment history, and realistic recovery goals.

A clinician may evaluate:

1. Diagnosis: Confirmation that symptoms arise from a condition for which PRP has demonstrated or emerging support.
2. Clinical status: Assessment of pain, range of motion, strength, mechanical function, and activity demands.
3. Treatment expectations: Discussion of realistic timelines, potential benefits, procedural discomfort, and rehabilitation requirements.

PRP may be considered when persistent joint-related symptoms limit mobility or participation despite appropriate conservative care. Shared decision-making allows patients, clinicians, and caregivers to weigh evidence, personal goals, and functional priorities. An individualized plan may include ultrasound guidance, staged rehabilitation, and outcome monitoring to support safe, purposeful recovery.

When Is PRP Not Recommended?

PRP is generally not recommended when the diagnosis is uncertain, the injury requires urgent surgical or other definitive treatment, or the expected benefit is unsupported by reliable clinical evidence. Careful evaluation is crucial because persistent pain may reflect fracture, infection, advanced osteoarthritis, tendon rupture, or referred neurologic disease rather than a condition likely to respond to platelet-based therapy.

Important PRP contraindications include active systemic or local infection, significant bleeding disorders, severe thrombocytopenia, and inability to pause medications that substantially impair platelet function when clinically appropriate. Infection risk is particularly concerning near a joint, implanted hardware, or compromised skin, where introducing biologic material could worsen tissue damage or delay definitive care. Treatment may also be deferred during pregnancy, acute illness, or uncontrolled inflammatory disease when safety data are limited.

Patients using anticoagulants, those with anemia, or individuals with unrealistic expectations require individualized assessment. A qualified clinician should review imaging, medications, comorbidities, and evidence for the specific joint and pathology before recommending PRP.

What Happens During PRP Treatment?

PRP treatment begins with patient preparation, including confirmation of the target joint, antiseptic skin cleansing, and positioning for accurate access. Blood is drawn, processed to concentrate platelets, and injected into the injured tissue under anatomical or ultrasound guidance. Recovery typically involves brief observation, activity modification, and follow-up to assess pain, function, and tissue response.

Preparing the Patient

Before treatment begins, the clinician reviews the patient’s medical history, medications, allergies, symptoms, and imaging to confirm that platelet-rich plasma (PRP) is appropriate for the affected joint or periarticular tissue. The medication review identifies anticoagulants, antiplatelet agents, corticosteroids, and supplements that may influence bleeding or platelet activity; adjustments occur only under medical guidance.

Preparation commonly includes:

1. Confirming the treatment site, diagnosis, goals, and informed consent.
2. Reviewing infection risks, skin conditions, fever, and conditions that could impair recovery.
3. Explaining hygiene expectations, including clean skin, appropriate clothing, and avoidance of lotions or topical products near the site.

The patient may be asked about hydration, recent illness, and relevant laboratory results. Anatomical landmarks and imaging findings guide procedural planning, while allergies and sensitivities inform antiseptic selection. Clear instructions help patients support safe, respectful care.

Injection and Recovery

Once preparation is complete, the clinician positions and sterilizes the treatment area, often using ultrasound guidance to identify the joint space, tendon, ligament, or other target tissue. Blood is drawn, centrifuged, and processed to concentrate platelets. A sterile needle then delivers PRP into or around the injured structure; brief pressure or soreness may occur.

Phase	Typical consideration
Blood draw	Small-volume venipuncture
Processing	Platelet concentration
Injection	Ultrasound-guided placement
Immediate care	Observation and dressing
Recovery	Gradual return to activity

Patients should follow individualized post injection precautions, including keeping the site clean, monitoring swelling, and contacting the clinician for fever, escalating pain, or neurologic changes. Activity modification commonly includes avoiding strenuous loading initially, then progressing through rehabilitation as tissue tolerance improves. Analgesic recommendations should be confirmed with the treating clinician.

How Long Does a PRP Injection Take?

How long a PRP injection takes depends on the joint treated, the preparation method, and whether imaging guidance is required. Most appointments last approximately 45–90 minutes, although the needle placement itself may require only several minutes. Time is also allocated for medical review, blood collection, centrifugation, sterile preparation, and post-procedure instructions.

A PRP injection appointment typically lasts 45–90 minutes, including preparation, blood processing, injection, and aftercare instructions.

A typical clinic workflow includes:

1. Assessment: The clinician confirms the target structure, reviews medications and contraindications, and discusses patient expectations, including possible Pain during venipuncture or injection.
2. Preparation: A small blood sample is processed to concentrate platelets, while the patient is positioned to expose the affected joint safely.
3. Injection: The clinician introduces the PRP into the intended intra-articular or periarticular region, sometimes using ultrasound or fluoroscopy for anatomical accuracy.

Patients should allow additional time for consent, questions, and observation afterward. Appointment duration varies with staffing, equipment, and clinic scheduling; confirming timing in advance helps patients arrange transportation, support, and work responsibilities without creating avoidable delays.

How Effective Is PRP for Joint Injuries?

Following the injection, PRP’s effectiveness for joint injuries depends on the affected tissue, injury severity, platelet formulation, and treatment protocol. Evidence suggests PRP may reduce pain and improve function in selected musculoskeletal injuries, but benefits are neither immediate nor uniform. Its biologic activity involves concentrated platelets releasing growth factors that may influence inflammation, vascular signaling, and extracellular-matrix remodeling at the injury site.

Clinical studies report Variable Outcomes because preparation methods, injection guidance, rehabilitation plans, and outcome measures differ substantially. Some patients experience meaningful improvement over several weeks, while others show limited change. The Tendon Response may be slower than symptom relief, reflecting gradual collagen organization and restoration of load tolerance. Treatment success should therefore be assessed through pain scores, range of motion, strength, and functional milestones rather than imaging alone. Care teams should explain that PRP is an adjunct to structured rehabilitation, not a guaranteed repair. Appropriate patient selection, precise anatomical placement, and follow-up remain essential for evaluating clinical benefit and supporting safe return to activity.

Can PRP Help Arthritis or Tendon Damage?

PRP may reduce pain associated with mild-to-moderate osteoarthritis by modulating inflammation within the affected joint, although it does not restore lost cartilage. In tendon injuries, concentrated platelets may support local tissue repair and remodeling, particularly when combined with structured rehabilitation. Clinical evidence remains variable, and treatment benefits are limited by arthritis severity, tendon pathology, preparation methods, and patient-specific factors.

PRP for Arthritis Pain

Arthritis pain and selected tendon injuries may respond to platelet-rich plasma (PRP) injections, which deliver concentrated autologous platelets to the affected tissue. In osteoarthritis, PRP is most often studied for the knee, where inflammatory mediators and cartilage degeneration contribute to pain and functional limitation. Evidence suggests modest, variable symptom improvement, rather than cartilage restoration or disease reversal. Appropriate prp treatment criteria may include persistent symptoms, confirmed structural diagnosis, failure of conservative care, and realistic expectations. Clinicians generally assess:

1. Joint severity, alignment, instability, and inflammatory conditions.
2. Medication use, bleeding risk, infection, and comorbidities.
3. Functional goals, rehabilitation capacity, and alternatives.

Reported arthritis pain outcomes differ by preparation method, injection protocol, disease stage, and follow-up duration. Shared decision-making helps clinicians support patients responsibly while emphasizing that PRP complements, rather than replaces, exercise, weight management, and evidence-based pain care.

Tendon Healing Potential

Tendon tissue has limited vascularity and recovers slowly, prompting interest in platelet-rich plasma (PRP) as a treatment for chronic tendinopathy and partial tendon damage. Tendon biology helps explain this vulnerability: densely aligned type I collagen, sparse tenocytes, and relatively low blood flow restrict rapid matrix repair after repetitive loading or injury. PRP may supply concentrated platelets and signaling proteins to the affected region, potentially supporting cellular activity, collagen remodeling, and local vascular responses. Its theoretical role is consequently regenerative support rather than immediate structural replacement. In arthritis, PRP may influence the joint environment and symptoms, but tendon applications focus on damaged fibers, entheses, or surrounding tissue. Healing limitations remain important, including lesion size, chronic degeneration, mechanical stress, and individual health factors that can constrain tissue repair.

Evidence and Treatment Limits

Clinical evidence suggests that platelet-rich plasma may reduce pain and improve function in selected cases of knee osteoarthritis and chronic tendon disorders, but its effects are variable and do not consistently restore damaged cartilage or tendon architecture. Evidence is stronger for symptom relief than structural regeneration, particularly in mild-to-moderate osteoarthritis and tendinopathies such as lateral epicondylitis or patellar tendinopathy. Patient selection criteria should include diagnosis, disease severity, activity demands, comorbidities, and failure of appropriate rehabilitation.

1. Strength and outcomes: Benefits may emerge gradually and depend on progressive loading, not injection alone.
2. Treatment limits: PRP cannot reliably reverse advanced cartilage loss, tendon rupture, instability, or severe mechanical deformity.
3. Clinical planning: Patients should receive realistic counseling, image-guided assessment when indicated, and coordinated rehabilitation.

Protocols, platelet concentration, injection technique, and follow-up vary, limiting direct comparison across studies.

When Will PRP Results Appear?

PRP results typically emerge gradually, with early changes sometimes appearing within several weeks and more substantial improvement developing over two to three months as treated tissues undergo repair and remodeling. The pain timeline varies according to the joint involved, injury severity, platelet concentration, and baseline tissue health. Some patients experience temporary soreness or increased stiffness during the first few days as the biologic response begins; others notice progressive symptom relief later.

Recovery expectations should reflect PRP’s role in supporting tissue repair rather than providing immediate analgesia. Tendons, ligaments, cartilage, and synovial structures remodel at different rates, so functional gains may continue for three to six months. Improved range of motion, walking tolerance, load capacity, or joint stability may precede complete pain reduction. Clinical studies show variable outcomes, and not every patient achieves meaningful improvement. Follow-up assessment helps clinicians distinguish expected repair from persistent inflammation, mechanical pathology, or complications requiring reassessment. This measured timeline supports informed decisions and realistic communication with patients and caregivers.

How Should You Prepare for PRP Therapy?

Because symptom improvement may develop gradually, preparation should support accurate treatment planning and an appropriate biologic response. Before treatment, the clinician reviews the injured joint, relevant imaging, diagnoses, allergies, bleeding history, and medical conditions that could alter safety or platelet function. A personalized Blood Test Checklist may be appropriate when anemia, thrombocytopenia, infection, or systemic illness is suspected.

1. Medication Adjustment: The clinician should review aspirin, nonsteroidal anti-inflammatory drugs, anticoagulants, corticosteroids, and supplements. Changes must be supervised; prescribed anticoagulants should never be stopped independently.
2. Health optimization: Patients should report fever, skin infection, recent antibiotics, pregnancy, autoimmune disease, or cancer treatment. Adequate hydration and a balanced meal plan may support venous blood collection, unless fasting is specifically required.
3. Procedure planning: Loose clothing should expose the target region, and transportation may be arranged if discomfort or anxiety could impair safe travel.

Patients should provide complete records and ask how their diagnosis, medications, and goals influence candidacy, helping the care team deliver individualized, ethical treatment.

What Is PRP Recovery Like?

Recovery after PRP therapy for a joint injury is typically gradual, with early soreness, swelling, or stiffness reflecting the injection and the intended inflammatory response rather than immediate tissue repair. Symptoms often settle over several days, while tendon, ligament, cartilage, or synovial repair may require weeks to months. The treating clinician should individualize timelines according to the joint, lesion, and functional demands.

Phase	Typical experience	Supportive care
First 48 hours	Local tenderness and guarded motion	Relative rest; prescribed analgesia
Days 3–7	Gradual symptom reduction	Gentle range-of-motion work
Weeks 2–6	Progressive strength return	Supervised home rehabilitation
Beyond 6 weeks	Functional improvement varies	Guided loading and reassessment

Activity modification commonly limits impact, heavy lifting, and repetitive loading before tissues tolerate progressive stress. Lifestyle adjustments, including adequate sleep, nutrition, and adherence to therapy, can support participation in recovery. Aftercare expectations should include scheduled follow-up and clear instructions for resuming work, caregiving, exercise, and daily activities. Progress is generally measured by pain, range of motion, strength, and function rather than imaging alone.

What Are the Risks of PRP Therapy?

What risks accompany PRP therapy? Although platelet-rich plasma uses the patient’s own blood, treatment is not risk-free. Temporary soreness, swelling, bruising, or stiffness may develop as the needle enters the joint or surrounding tendon and as the tissue responds to concentrated platelets. Symptoms usually resolve, but persistent or worsening pain requires clinical assessment.

PRP therapy may cause temporary soreness, swelling, bruising, or stiffness, though persistent or worsening pain requires clinical assessment.

1. Infection Risk: Skin penetration creates a small possibility of infection within the joint, bursa, or soft tissue. Sterile preparation and appropriate post-procedure monitoring reduce this concern. Fever, increasing redness, drainage, or severe pain warrants urgent evaluation.
2. Bleeding and nerve injury: Patients using anticoagulants or those with bleeding disorders may experience prolonged bleeding or hematoma. Incorrect needle placement can irritate nearby nerves or blood vessels, although ultrasound guidance may improve anatomical precision.
3. Allergic Reactions: Reactions to local anesthetics, antiseptic agents, dressings, or other injected materials can occur, even when the platelet preparation itself is autologous. Patients should disclose allergies, medications, immune conditions, and prior injection complications before treatment to support safe, individualized care.

How Much Does PRP Therapy Cost?

How much PRP therapy costs depends on the treated joint, the number of injections required, preparation methods, imaging guidance, and the provider’s knowledge. PRP cost factors also include whether treatment targets a superficial tendon, a deep hip joint, or a complicated spinal-adjacent structure. Clinics may charge per injection, with pricing ranges commonly spanning several hundred to more than a thousand dollars per session, although fees vary substantially by region and technique.

Insurance coverage is inconsistent because many carriers classify PRP as investigational or elective, particularly when evidence remains limited for a specific diagnosis. Patients should request a written estimate identifying consultation, blood collection, processing, ultrasound or fluoroscopic guidance, injection, and follow-up charges. A responsible clinician should explain the expected number of sessions without guaranteeing symptom relief or avoiding conventional care when indicated. Payment plans may be available through the practice or medical-financing providers. Comparing itemized costs, clinician qualifications, and evidence for the affected anatomy helps patients and caregivers make informed, service-oriented decisions.

Frequently Asked Questions

Can I Drive Myself Home After PRP Treatment?

Driving home after PRP treatment depends on effects timing, injection site, and sedation details. For driving safety, patients should arrange transportation, observe post treatment rest, and resume driving only when sensation, strength, coordination, and alertness normalize.

Will My Insurance Cover PRP Therapy for Joint Injuries?

Insurance coverage for PRP therapy varies because many plans classify it as investigational. Clinics perform PRP insurance verification, checking benefits and preauthorization requirements; patients should confirm deductibles, exclusions, medical-necessity criteria, and potential out-of-pocket costs beforehand.

Can PRP Therapy Be Combined With Physical Therapy?

Yes, PRP therapy can complement physical therapy when PRP timing, physical therapy alignment, and post injection activity are coordinated. Clinicians individualize the rehab protocol according to tissue recovery, pain response, joint stability, and functional goals.

How Many PRP Injections Might I Need?

Patients may require one to three PRP injections, depending on diagnosis, tissue involvement, and clinical response. The treatment plan determines injection frequency; response based dosing guides subsequent sessions, emphasizing individualized, evidence-informed care.

Should I Stop Taking Supplements Before PRP Therapy?

Whether supplements should stop depends on their ingredients and bleeding effects. Clinicians commonly review fish oil, vitamin E, turmeric, and herbal products individually. Medication timing and hydration guidance should come from the treating provider.

—————————

PRP therapy may offer a biologically focused option for selected joint injuries, particularly when symptoms persist despite appropriate conservative care. However, benefits vary by diagnosis, tissue involved, preparation method, and patient factors. At Michigan Center for Regenerative Medicine, a thorough evaluation can help confirm the pain source, assess structural damage, and establish realistic expectations. Patients should discuss indications, alternatives, costs, and potential risks with a qualified clinician before treatment. PRP should complement—not replace—rehabilitation and evidence-based joint care.